Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
You currently have no recent searches
Matsuo, Tomoaki1; Nakata, Yoshio1; Okura, Tomohiro1; Hotta, Kikuko2; Tanaka, Kiyoji FACSM1
1University of Tsukuba, Tsukuba, Japan.
2Institure of Physical and Chemical Research, Yokohama, Japan.
An individual's genetic information, which is available as an additional determinant for body-weight reduction, may be able to modify the weight reduction program. Single-nucleotide polymorphism (SNP) is one of the important factors to explain various differences in human individuals. Peroxisome proliferator activated receptor (PPAR) plays a key role in the regulation of lipid and glucose metabolisms and body fat distribution. Several researchers suggest a significant relationship between the PPAR genotype and body-weight change. It is unclear, however, whether PPAR genotype is a useful as decisive factor in weight-reduction.
PURPOSE: To investigate the relationship between the PPAR genotype and body-weight change in response to a 14-week intervention, and to quantify the contribution of PPAR genotype as additional information for weight reduction program.
METHODS: In total, 282 middle-aged Japanese women (age, 48.9±9.1 years; body mass index, 27.1±3.1 kg/m2) participated in a 14-week diet and exercise intervention program as subjects. Genetic information about PPAR was analyzed (7 SNPs of peroxisome proliferator activated receptor γ; PPARG, 3 SNPs of peroxisome proliferator activated receptor α; PPARA and 10 SNPs of peroxisome proliferator activated receptor γ coactivator 1; PPARGC1).
RESULTS: Body-weight decreased significantly (−7.9±3.0 kg, −11.9±4.0%) following the intervention. An analysis of covariance (ANCOVA) was used to test for differences in the amount of body-weight reduction among each of the genotypes using baseline body mass index as a covariate. As a result, only one SNP (PPARG) had a strong relationship (p = 0.0009) with the amount of body-weight reduction. In a multiple regression model, baseline body mass index accounted for 12% of the total variance in body-weight change. The percentage increased to 17% when PPAR genotype was included the model.
CONCLUSIONS: These data suggest that PPAR genotype influences the change in body-weight in response to a 14-week weight reduction intervention among obese middle-aged Japanese women. The PPAR genotype accounted for additional 5% of the total body-weight reduction variance.
©2007The American College of Sports Medicine
Colleague's E-mail is Invalid
Your Name: (optional)
Separate multiple e-mails with a (;).
Thought you might appreciate this item(s) I saw at Medicine & Science in Sports & Exercise.
Send a copy to your email
Your message has been successfully sent to your colleague.
Some error has occurred while processing your request. Please try after some time.
An Existing Folder
A New Folder
The item(s) has been successfully added to "".
Login with your LWW Journals username and password.
Username or Email:
Enter and submit the email address you registered with. An email with instructions to reset your password will be sent to that address.
Link to reset your password has been sent to specified email address.
What does "Remember me" mean?
By checking this box, you'll stay logged in until you logout. You'll get easier access to your articles, collections,
media, and all your other content, even if you close your browser or shut down your
To protect your most sensitive data and activities (like changing your password),
we'll ask you to re-enter your password when you access these services.
What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend
that you uncheck the "Remember me" box.
Save my selection
Article Level Metrics